Previous 10 | Next 10 |
Gainers: AnPac Bio-Medical Science (ANPC) +110%, Cocrystal Pharma (COCP) +56%, Renalytix AI (RNLX) +31%, Precigen (PGEN) +13%, Chiasma (CHMA) +11%.Losers: Hepion Pharmaceuticals (HEPA) -29%, Medigus (MDGS) -12%, Retractable Technologies (...
AnPac Bio-Medical Science (ANPC) +95% on Q3 record test volume.Mmtec (MTC) +50%.Yunji (YJ) +46% on deal with Bytedance's live streaming platform.Weidai (WEI) +30%.Safe-T Group Ltd (SFET) +22% on Q3 results.Molecular Data (MKD) +22%.21Vianet Group (VNET) +20%...
Are Analysts Right About Some Of These Penny Stocks? After several weeks of rallies in the stock market, investors are continuing to pay attention to penny stocks . On November 24th, the stock market had one of the best days in months. Tuesday saw the Dow Jones Industrial Average sh...
Cocrystal Pharma (COCP): Q3 GAAP EPS of -$0.05.Revenue of $0.49M (flat Y/Y) misses by $0.09M.Shares +0.3% PM.10QPress Release For further details see: Cocrystal Pharma misses on revenue
– Continued progress of COVID-19 development programs with additional preclinical studies of coronavirus protease inhibitors (3CL) underway and lead preclinical molecule selection expected by year end – – Ongoing Merck collaboration to discover and develop i...
BOTHELL, WA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announ...
– Live video webcast with the Cocrystal management team, on Thursday, November 12 th at 12:00 PM EST – BOTHELL, WA, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”),...
– New in vitro data demonstrating antiviral activity with lead compound CC-42344 against Xofluza (baloxavir)-resistant H1N1 strain – – Company continues to advance IND-enabling studies for Phase 1 clinical study in 2021 – BOTHELL, WA, Oc...
Penny Stocks Under $1 To Watch Right Now; 1 Up Over 65% After-Hours Penny stocks come in all shapes and sizes. They range anywhere from the cheapest penny stocks at $0.0001 to the high end of $4.9999. Whether you’re buying the cheapest of these or the “most expensi...
BOTHELL, WA, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP) The following is being released by Cocrystal Pharma, Inc. pursuant to an order of the United States District Court, District of New Jersey, regarding Agreement of Settlement. UNITED STA...
News, Short Squeeze, Breakout and More Instantly...
Cocrystal Pharma Inc. Company Name:
COCP Stock Symbol:
NASDAQ Market:
Cocrystal Pharma Inc. Website:
BOTHELL, Wash., July 18, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) today reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of the Phase 1 study in healthy volunteers wit...
BOTHELL, Wash., June 20, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc .’s (Nasdaq: COCP) novel, broad-spectrum antiviral CC-42344 inhibits activity in the highly pathogenic avian influenza A (H5N1) PB2 protein recently identified in infected dairy cattle, according to recently ...
Topline single ascending dose (SAD) Phase 1 results of oral CDI-988, the first potential pan-coronavirus-pan-norovirus oral antiviral, expected in the second quarter of 2024 Enrollment completed in Phase 2a influenza A human challenge study of oral CC-42344, with topline results expected ...